Growth Metrics

Biofrontera (BFRI) Income towards Parent Company: 2021-2024

Historic Income towards Parent Company for Biofrontera (BFRI) over the last 4 years, with Dec 2024 value amounting to -$17.8 million.

  • Biofrontera's Income towards Parent Company fell 17.29% to -$6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.6 million, marking a year-over-year decrease of 36.89%. This contributed to the annual value of -$17.8 million for FY2024, which is 11.78% up from last year.
  • As of FY2024, Biofrontera's Income towards Parent Company stood at -$17.8 million, which was up 11.78% from -$20.1 million recorded in FY2023.
  • Over the past 5 years, Biofrontera's Income towards Parent Company peaked at -$640,000 during FY2022, and registered a low of -$37.7 million during FY2021.
  • Over the past 3 years, Biofrontera's median Income towards Parent Company value was -$17.8 million (recorded in 2024), while the average stood at -$12.8 million.
  • In the last 5 years, Biofrontera's Income towards Parent Company skyrocketed by 98.30% in 2022 and then crashed by 3,045.47% in 2023.
  • Over the past 4 years, Biofrontera's Income towards Parent Company (MRY) stood at -$37.7 million in 2021, then skyrocketed by 98.30% to -$640,000 in 2022, then tumbled by 3,045.47% to -$20.1 million in 2023, then increased by 11.78% to -$17.8 million in 2024.
  • Its Income towards Parent Company was -$17.8 million in FY2024, compared to -$20.1 million in FY2023 and -$640,000 in FY2022.